Yimmugo 10 % in 100 ML Injection
- RxCUI
- 2706396
- RxNorm name
- Yimmugo 10 % in 100 ML Injection
- Display name
- Yimmugo 10 % in 100 ML Injection
- Full name
- Yimmugo 10 % in 100 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:04
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125810 | YIMMUGO | immune globulin intravenous, human-dira | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 77aaac18-f2af-46c4-8f65-b15be1cec3c2 | Yimmugo 10 % in 100 ML Injection [PSN] · 100 ML immune globulin intravenous (human) - dira 100 MG/ML Injection [Yimmugo] [SBD] · 100 ML Yimmugo 100 MG/ML Injection [SY] | 3 | 6 | These highlights do not include all the information needed to use YIMMUGO safely and effectively. See full prescribing information for YIMMUGO. YIMMUGO (immune globulin intravenous, human - dira), 10% liquid Initial U.S. Approval: 2024 | 20260301 |